We have compiled a list of manufacturers, distributors, product information, reference prices, and rankings for Diagnostic Equipment.
ipros is IPROS GMS ・ IPROS One of the largest technical database sites in Japan that collects information on.

Diagnostic Equipment×Panorama Data Insights Ltd. - List of Manufacturers, Suppliers, Companies and Products

Diagnostic Equipment Product List

1～3 item / All 3 items

Displayed results
[Market Research Report] AI Market in Global Medical Imaging Diagnostics

[Market Research Report] AI Market in Global Medical Imaging Diagnostics

The AI market in medical imaging diagnostics worldwide is expected to see unprecedented growth, projected to reach 20.9 billion dollars by 2030.

The global market for AI in medical imaging diagnostics, which was valued at $1.7 billion in 2022, is projected to reach an astonishing $20.9 billion by 2030, according to recent market analysis. This represents a compound annual growth rate (CAGR) of 36.87% during the forecast period from 2022 to 2030, symbolizing the rapid technological advancements and acceptance of AI in the healthcare sector. The utilization of AI in medical imaging diagnostics is driven by factors such as increased collaboration and partnerships across industries, government initiatives supporting the use of AI-based technologies, concentrated efforts to alleviate the workload of radiologists, the proliferation of AI tools in the medical field, and a rise in funding for AI-based startups from private investors. In the foreseeable future, advancements in AI tools and technologies are expected to significantly transform the healthcare and radiology industries. Current market participants are optimistic that the increasing adoption of AI, particularly in the field of radiology, will unlock extensive opportunities and contribute to the growth of the AI market in medical imaging diagnostics.

  • others

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Global liver cancer diagnostics market

Global liver cancer diagnostics market

As the importance of early detection and early treatment of liver cancer increases, the global market for liver cancer diagnostic drugs shows promising growth.

The global liver cancer diagnostics market is experiencing significant growth as attention to the early detection and treatment of liver cancer (hepatocellular carcinoma) increases. Liver cancer is a leading cause of cancer-related deaths worldwide. Proper and accurate diagnosis plays a crucial role in improving patient outcomes and survival rates. According to the latest market report, the market revenue for liver cancer diagnostics reached $2.1 billion in 2021 and is expected to grow steadily at a compound annual growth rate (CAGR) of 8.2% during the forecast period from 2022 to 2030, reaching $4.6 billion by 2030. The rising incidence of liver cancer is driven by factors such as hepatitis B and C infections, alcohol-related liver disease, and non-alcoholic fatty liver disease (NAFLD), which are fueling the demand for effective diagnostic tools. Liver cancer diagnostics include imaging technologies such as ultrasound, CT (computed tomography), MRI (magnetic resonance imaging), and PET (positron emission tomography), as well as blood tests and biopsies, which are used to accurately identify the presence and stage of liver cancer. For application methods, please check the [PDF download] button or apply directly through the related links.

  • others

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Market Report] Global Market for Preimplantation Genetic Diagnosis (PGD)

[Market Report] Global Market for Preimplantation Genetic Diagnosis (PGD)

The global market for preimplantation genetic diagnosis (PGD) is expected to reach new heights by 2031, with an estimated value of 198,603.5 thousand US dollars.

The global preimplantation genetic diagnosis (PGD) market has achieved remarkable growth, providing hope and advanced solutions for individuals and couples aiming to expand their families. The sales revenue in 2022 was approximately $81,520.2 thousand, but it is estimated to soar to $198,603.5 thousand by 2031, with a steady compound annual growth rate (CAGR) of 10.4% projected during the forecast period from 2023 to 2031. The global PGD market is at the forefront of technological innovation in reproductive medicine. With advancements in medicine, the ability to conduct genetic testing on preimplantation embryos has significantly changed family planning. PGD enables individuals and couples to make informed decisions by identifying genetic abnormalities, hereditary diseases, and chromosomal abnormalities that could affect the health of future children. You can check the application method by clicking the [PDF Download] button or apply directly through the related links.

  • others

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
COPYRIGHT © 2001-2025 IPROS CORPORATION ALL RIGHTS RESERVED.